[ad_1] LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) — As per The Business Research Company’s RNA Targeting Small Molecules Therapeutics Global Market Report 2023, the RNA Targeting Small Molecules Therapeutics market…
Tag: Therapeutics
Monash University joins forces with spin-out Orio Therapeutics to transform regenerative medicine
[ad_1] You are here: 09 October 2023 Monash University Commercialisation and Faculty of Medicine, Nursing and Health Sciences (MNHS) Business Development teams have…
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
[ad_1] The deal expands the pharmaceutical company’s portfolio of cancer drugs. [ad_2] Source link
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
[ad_1] Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® (adagrasib), a…
Microbiome Therapeutics Market Report, Cost Estimation, Business Plan 2035 – DuPont de Nemours (NYSE:DD), Seres Therapeutics (NASDAQ:MCRB)
[ad_1] Research Nester released a report titled “Microbiome Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2029″ which delivers detailed overview of the global microbiome therapeutics market in terms of…
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
[ad_1] Aykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup’s experimental obesity pill succeeded in a small early-stage…
Better Therapeutics Completes Enrollment in Real-World Evidence Program Evaluating Long-term Effectiveness of AspyreRx in Type 2 Diabetes
[ad_1] Better Therapeutics Completes Enrollment in Real-World Evidence … WV News [ad_2] Source link
Laverock Therapeutics raises £13.5m for gene silencing platform – Business Leader News
[ad_1] Laverock Therapeutics raises £13.5m for gene silencing platform Business Leader [ad_2] Source link
Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting
[ad_1] SAN DIEGO, Sept. 25, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor therapies, today…
Chinese Patent Granted for CytoMed Therapeutics’ Licensed iPSC-Based Technology
[ad_1] SINGAPORE, Sept. 25, 2023 /PRNewswire/ — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic…